Estia Health Future Growth

Future criteria checks 4/6

Estia Health is forecast to grow earnings and revenue by 67% and 7% per annum respectively while EPS is expected to grow by 86.5% per annum.

Key information

67.0%

Earnings growth rate

86.5%

EPS growth rate

Healthcare earnings growth	23.1%
Revenue growth rate	7.0%
Future return on equity	n/a
Analyst coverage	Low
Last updated	06 Dec 2023

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:26E - Analysts future estimates and past financials data (AUD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2026	976	49	N/A	167	3
6/30/2025	941	46	94	149	4
6/30/2024	870	-19	101	172	4
6/30/2023	754	-34	126	187	N/A
3/31/2023	721	-52	75	130	N/A
12/31/2022	689	-70	24	73	N/A
9/30/2022	680	-61	23	64	N/A
6/30/2022	671	-52	22	56	N/A
3/31/2022	668	-25	54	87	N/A
12/31/2021	665	3	86	118	N/A
9/30/2021	656	4	47	86	N/A
6/30/2021	646	6	7	55	N/A
3/31/2021	645	-66	11	66	N/A
12/31/2020	643	-137	14	77	N/A
9/30/2020	640	-127	30	102	N/A
6/30/2020	637	-117	45	126	N/A
3/31/2020	625	-41	27	113	N/A
12/31/2019	612	35	8	101	N/A
9/30/2019	599	38	1	94	N/A
6/30/2019	586	41	-6	88	N/A
3/31/2019	575	42	7	96	N/A
12/31/2018	565	42	20	105	N/A
9/30/2018	556	42	49	121	N/A
6/30/2018	547	41	78	137	N/A
3/31/2018	540	41	85	138	N/A
12/31/2017	533	41	92	139	N/A
9/30/2017	529	41	91	139	N/A
6/30/2017	525	41	90	139	N/A
3/31/2017	517	36	N/A	148	N/A
12/31/2016	510	31	N/A	158	N/A
9/30/2016	476	29	N/A	150	N/A
6/30/2016	443	28	N/A	142	N/A
3/31/2016	400	27	N/A	146	N/A
12/31/2015	357	27	N/A	150	N/A
9/30/2015	321	2	N/A	127	N/A
6/30/2015	285	-23	N/A	104	N/A
3/31/2015	228	-30	N/A	71	N/A
12/31/2014	171	-38	N/A	38	N/A
9/30/2014	119	-26	N/A	24	N/A
6/30/2014	67	-14	N/A	10	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 26E is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.5%).

Earnings vs Market: 26E is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 26E is expected to become profitable in the next 3 years.

Revenue vs Market: 26E's revenue (7% per year) is forecast to grow faster than the German market (4.6% per year).

High Growth Revenue: 26E's revenue (7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 26E's Return on Equity is forecast to be high in 3 years time

Estia Health Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Recent updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings released: AU$0.13 loss per share (vs AU$0.20 loss in FY 2022)

Estia Health Limited (ASX:EHE) entered into a binding agreement to acquire residential aged care homes in Benalla of Royal Freemasons Ltd.

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Bain Capital Reportedly Moves to Sell Craigcare But Abandons Its Pursuit of Estia

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

CEO, MD & Director recently bought €68k worth of stock

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Full year 2022 earnings released: AU$0.20 loss per share (vs AU$0.021 profit in FY 2021)

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Estia Health Limited Appoints Sean Bilton as Director

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Insufficient new directors

Estia Health Limited Announces Management Changes

Estia Health Limited announces resignation of Hon. Warwick L. Smith AO as director, effective 31 March 2022

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Estia Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.45 loss in FY 2020)

First half 2021 earnings released: AU$0.02 loss per share (vs AU$0.055 profit in 1H 2020)

Estia Health Limited Not Declare Interim Dividend for the Six Months Ended December 31, 2020

Estia Health Limited Reaches an Agreement to Settle the Shareholder Class Action Commenced Against It in July 2019

New 90-day high: €1.22

New 90-day high: €1.13

Estia Health Limited to Report Q2, 2021 Results on Feb 23, 2021

New 90-day high: €0.96

New 90-day low: €0.80

New 90-day low: €0.82

Non-Executive Director recently bought €62k worth of stock

Full year earnings released

Estia Health Limited Determines Not to Declare A Final Dividend for Fiscal Year 2020

Estia Health Limited(ASX:EHE) dropped from S&P/ASX 200 Index

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies